We examined the current literature to understand factors that influence endocrine therapy
(ET) adherence among racial/ethnic and socioeconomic subpopulations of breast cancer …

Black women in the US have significantly higher breast cancer mortality than White women.
Within biomarker-defined tumor subtypes, disparate outcomes seem to be limited to women …

Breast cancer is the most commonly diagnosed cancer worldwide and is one of the leading
causes of cancer death. The incidence, pathological features, and clinical outcomes in …

Objective To describe the estimated prevalence and temporal trends of chronic kidney
disease (CKD) treatment patterns, and the association between CKD and potential factors …

Purpose Racial variation in the financial impact of cancer may contribute to observed
differences in the use of guideline-recommended treatments. We describe racial differences …

Abstract Background: African American and Hispanic women are more likely to be
diagnosed with aggressive forms of breast cancer. Disparities within each subtype of breast …

Objective: To determine the association between race/ethnicity and perioperative outcomes
in individuals undergoing major oncologic and nononcologic surgical procedures in the …

Background Differential use of endocrine therapy (ET) by race may contribute to breast
cancer outcome disparities, but racial differences in ET behaviors are poorly understood …

Background After controlling for baseline disease factors, researchers have found that black
women have worse breast cancer survival, and this suggests that treatment differences may …

Purpose Poor and underserved women face barriers in receiving timely and appropriate
breast cancer care. Patient navigators help individuals overcome these barriers, but little is …